[
    {
        "scene": null,
        "question": {
            "CASE_CORE": {
                "VISIT_DATE": "2023-01-03",
                "last_platinum_end_date": "2022-08-17",
                "first_relapse_date": "2022-10-12",
                "PFI_days": "56",
                "PLATINUM_STATUS": "Resistant",
                "PLATINUM_STATUS_CURRENT": "Resistant",
                "PLATINUM_PFI_CURRENT": "56",
                "SCENE": "Platinum_resistant_relapse",
                "PLATINUM_HISTORY": [
                    {
                        "line": "1L",
                        "start_date": "Unknown",
                        "end_date": "2022-08-17",
                        "first_relapse_date": "2022-10-12",
                        "PFI_days": "56",
                        "status": "Resistant",
                        "evidence_type": "Biochemical",
                        "evidence": "CA125:89.60U/ml (2022-10-12)"
                    }
                ],
                "DIAGNOSIS": {
                    "primary": "卵巢癌复发",
                    "histology": "首先考虑为透明细胞癌",
                    "site": "卵巢",
                    "laterality": "Unknown",
                    "components": [
                        "高级别腺癌"
                    ]
                },
                "STAGE": {
                    "stage_text": "Unknown",
                    "stage_system": "Unknown",
                    "stage_basis": "Unknown"
                },
                "INITIAL_TREATMENT": "Yes",
                "SURGERY_DONE": {
                    "performed": "Yes",
                    "date": "2022-03-28",
                    "procedure": "Debulking surgery + partial rectosigmoid resection + partial vaginectomy + retroperitoneal lesion resection + complex adhesiolysis + left ureteral stent placement + bladder repair"
                },
                "NEOADJUVANT": "Unknown",
                "ADJUVANT_TREATMENT": {
                    "given": "Yes",
                    "regimens": [
                        "白紫+卡铂"
                    ],
                    "cycles_or_courses": "6 cycles"
                },
                "LINE_OF_THERAPY": [
                    {
                        "line": "1L",
                        "intent": "Adjuvant",
                        "regimen": "白紫+卡铂",
                        "start_date": "Unknown",
                        "end_date": "2022-08-17",
                        "cycles": "6"
                    }
                ],
                "MAINTENANCE": "Unknown",
                "MAINTENANCE_DETAIL": {
                    "given": "Unknown",
                    "regimens": [],
                    "start_date": "Unknown",
                    "end_date": "Unknown"
                },
                "RELAPSE": "Yes",
                "RELAPSE_DATE": {
                    "date": "2022-10-12",
                    "type": "Biochemical",
                    "evidence": "CA125:89.60U/ml"
                },
                "HRD": "Unknown",
                "BRCA1": "Unknown",
                "BRCA2": "Unknown",
                "BIOMARKERS": {
                    "TMB": "Unknown",
                    "MSI": "Unknown",
                    "PDL1_CPS": "Unknown",
                    "HER2": "Unknown",
                    "AFP": "<0.91 ng/ml (2022-10-12)",
                    "CA125": "933.00 U/ml (2022-12-29)"
                },
                "CURRENT_STATUS": "Recurrent ovarian carcinoma with hepatic and pelvic metastatic disease",
                "TIMELINE": {
                    "events": [
                        {
                            "date": "2022-03-28",
                            "event_type": "Surgery",
                            "description": "Debulking surgery with multiple procedures (partial rectosigmoid resection, partial vaginectomy, retroperitoneal lesion resection, left ureteral stent, bladder repair)",
                            "regimen_or_test": "Surgery",
                            "key_result": "Tumor ~7*4*2.5cm; full-thickness intestinal wall high-grade adenocarcinoma; consider clear cell carcinoma"
                        },
                        {
                            "date": "2022-08-17",
                            "event_type": "Chemo",
                            "description": "Postoperative chemotherapy completed: 白紫+卡铂, 6 cycles",
                            "regimen_or_test": "白紫+卡铂",
                            "key_result": "Last administration recorded 2022-08-17"
                        },
                        {
                            "date": "2022-10-12",
                            "event_type": "Lab",
                            "description": "Tumor markers rising after chemotherapy",
                            "regimen_or_test": "CA125, CA19-9, HE4, AFP",
                            "key_result": "CA19-9:77.20U/ml; CA125:89.60U/ml; AFP:<0.91ng/ml"
                        },
                        {
                            "date": "2022-10-24",
                            "event_type": "Imaging",
                            "description": "MRI: pelvic post-op, presacral mass increased; pelvic mesenteric enhancing nodules",
                            "regimen_or_test": "MRI pelvis",
                            "key_result": "Consider recurrence with adjacent sacral involvement; pelvic mesenteric nodules suggest metastases"
                        },
                        {
                            "date": "2022-10-25",
                            "event_type": "Imaging",
                            "description": "CT: multiple hepatic nodules, some new, likely metastases",
                            "regimen_or_test": "CT abdomen",
                            "key_result": "Multiple liver lesions, consider metastases"
                        },
                        {
                            "date": "2022-12-29",
                            "event_type": "Lab",
                            "description": "Tumor markers markedly elevated",
                            "regimen_or_test": "CA125, CA19-9, HE4, CA15-3",
                            "key_result": "CA19-9:229.00U/ml; CA125:933.00U/ml; HE4:111.00pmol/L"
                        },
                        {
                            "date": "2022-12-30",
                            "event_type": "Imaging",
                            "description": "MRI and CT show progression: increased presacral mass, new right iliac bone lesion, more hepatic metastases",
                            "regimen_or_test": "MRI pelvis, CT abdomen",
                            "key_result": "Pelvic presacral mass increased; right iliac bone enhancing nodule; hepatic metastases increased"
                        }
                    ],
                    "constraints": {
                        "min_events": 3,
                        "max_events": 30,
                        "must_include": [
                            "first diagnostic imaging or pathology confirmation (if available)"
                        ],
                        "ordering_rules": {
                            "prioritize_last_event": true
                        }
                    }
                }
            },
            "TIMELINE": {
                "events": [
                    {
                        "date": "2022-03-28",
                        "event_type": "Surgery",
                        "description": "Debulking surgery with multiple procedures (partial rectosigmoid resection, partial vaginectomy, retroperitoneal lesion resection, left ureteral stent, bladder repair)",
                        "regimen_or_test": "Surgery",
                        "key_result": "Tumor ~7*4*2.5cm; full-thickness intestinal wall high-grade adenocarcinoma; consider clear cell carcinoma"
                    },
                    {
                        "date": "2022-08-17",
                        "event_type": "Chemo",
                        "description": "Postoperative chemotherapy completed: 白紫+卡铂, 6 cycles",
                        "regimen_or_test": "白紫+卡铂",
                        "key_result": "Last administration recorded 2022-08-17"
                    },
                    {
                        "date": "2022-10-12",
                        "event_type": "Lab",
                        "description": "Tumor markers rising after chemotherapy",
                        "regimen_or_test": "CA125, CA19-9, HE4, AFP",
                        "key_result": "CA19-9:77.20U/ml; CA125:89.60U/ml; AFP:<0.91ng/ml"
                    },
                    {
                        "date": "2022-10-24",
                        "event_type": "Imaging",
                        "description": "MRI: pelvic post-op, presacral mass increased; pelvic mesenteric enhancing nodules",
                        "regimen_or_test": "MRI pelvis",
                        "key_result": "Consider recurrence with adjacent sacral involvement; pelvic mesenteric nodules suggest metastases"
                    },
                    {
                        "date": "2022-10-25",
                        "event_type": "Imaging",
                        "description": "CT: multiple hepatic nodules, some new, likely metastases",
                        "regimen_or_test": "CT abdomen",
                        "key_result": "Multiple liver lesions, consider metastases"
                    },
                    {
                        "date": "2022-12-29",
                        "event_type": "Lab",
                        "description": "Tumor markers markedly elevated",
                        "regimen_or_test": "CA125, CA19-9, HE4, CA15-3",
                        "key_result": "CA19-9:229.00U/ml; CA125:933.00U/ml; HE4:111.00pmol/L"
                    },
                    {
                        "date": "2022-12-30",
                        "event_type": "Imaging",
                        "description": "MRI and CT show progression: increased presacral mass, new right iliac bone lesion, more hepatic metastases",
                        "regimen_or_test": "MRI pelvis, CT abdomen",
                        "key_result": "Pelvic presacral mass increased; right iliac bone enhancing nodule; hepatic metastases increased"
                    }
                ],
                "constraints": {
                    "min_events": 3,
                    "max_events": 30,
                    "must_include": [
                        "first diagnostic imaging or pathology confirmation (if available)"
                    ],
                    "ordering_rules": {
                        "prioritize_last_event": true
                    }
                }
            },
            "MED_ONC": {
                "current_regimen": {
                    "name": "Unknown",
                    "last_admin_date": "Unknown",
                    "cycle_info": "Unknown"
                },
                "planned_next_regimen": "Unknown",
                "prior_systemic_therapies": [
                    "白紫+卡铂 (6 cycles)"
                ],
                "genetic_testing": {
                    "somatic": [],
                    "germline": []
                },
                "monitoring_points": []
            },
            "RADIOLOGY": {
                "studies": [
                    {
                        "date": "2022-10-24",
                        "modality": "MRI",
                        "anatomic_sites": [
                            "pelvis",
                            "sacrum"
                        ],
                        "findings": [
                            "Pelvis post-op changes",
                            "presacral mass, consider recurrence with adjacent sacral involvement",
                            "multiple enhancing small mesenteric nodules in pelvis, suggest metastases"
                        ],
                        "impression": "Recurrence with possible sacral involvement and pelvic mesenteric metastases",
                        "trend_vs_prior": "Worse"
                    },
                    {
                        "date": "2022-10-25",
                        "modality": "CT",
                        "anatomic_sites": [
                            "liver"
                        ],
                        "findings": [
                            "Multiple hepatic nodules, some new compared to prior",
                            "hepatic cysts unchanged"
                        ],
                        "impression": "Multiple liver lesions, consider metastases",
                        "trend_vs_prior": "Worse"
                    },
                    {
                        "date": "2022-12-30",
                        "modality": "MRI",
                        "anatomic_sites": [
                            "pelvis",
                            "right iliac bone",
                            "sacrum",
                            "rectum"
                        ],
                        "findings": [
                            "Presacral mass increased in range with heterogeneous enhancement",
                            "new enhancing nodule in right iliac bone",
                            "multiple pelvic mesenteric enhancing nodules",
                            "rectal local bowel wall thickening with enhancement"
                        ],
                        "impression": "Progressive pelvic recurrence with possible peritoneal and sacral involvement; new right iliac bone lesion",
                        "trend_vs_prior": "Worse"
                    },
                    {
                        "date": "2022-12-30",
                        "modality": "CT",
                        "anatomic_sites": [
                            "liver",
                            "spleen"
                        ],
                        "findings": [
                            "Multiple hepatic metastatic nodules increased in number and size",
                            "patchy splenic shadow, possible splenic infarct"
                        ],
                        "impression": "Progressive hepatic metastases; splenic abnormality noted, follow-up suggested",
                        "trend_vs_prior": "Worse"
                    }
                ],
                "next_imaging_plan": {
                    "modality": "Unknown",
                    "timing": "Unknown"
                }
            },
            "PATHOLOGY": {
                "specimens": [
                    {
                        "date": "2022-03-28",
                        "site": "partial rectosigmoid + left retroperitoneal tumor + partial vagina",
                        "diagnosis": "部分直乙结肠+左侧腹膜后肿瘤+部分阴道: 肠壁全层见高级别腺癌，结合T2022-04771首先考虑为透明细胞癌；可符合卵巢透明细胞癌累及。",
                        "components": [
                            "高级别腺癌"
                        ],
                        "grade": "Unknown",
                        "tumor_size": "7*4*2.5cm",
                        "laterality": "Unknown",
                        "sample_type": "Surgical resection",
                        "involvement_sites": [
                            "intestinal wall full thickness",
                            "peritoneum (left retroperitoneal tumor)",
                            "vagina (partial)"
                        ],
                        "ihc": [
                            {
                                "marker": "MLH1",
                                "result": "(+)"
                            },
                            {
                                "marker": "MSH6",
                                "result": "(+)"
                            },
                            {
                                "marker": "MSH2",
                                "result": "(+)"
                            },
                            {
                                "marker": "PMS2",
                                "result": "(+)"
                            },
                            {
                                "marker": "ER",
                                "result": "(部分+)"
                            },
                            {
                                "marker": "PR",
                                "result": "(少弱+)"
                            },
                            {
                                "marker": "P53",
                                "result": "(+/-)"
                            },
                            {
                                "marker": "WT1",
                                "result": "(-)"
                            },
                            {
                                "marker": "Ki-67",
                                "result": "(60%+)"
                            },
                            {
                                "marker": "HNF1B",
                                "result": "(+)"
                            },
                            {
                                "marker": "NapsinA",
                                "result": "(灶+)"
                            },
                            {
                                "marker": "P16",
                                "result": "(+)"
                            },
                            {
                                "marker": "PAX8",
                                "result": "(+)"
                            },
                            {
                                "marker": "SALL4",
                                "result": "(-)"
                            },
                            {
                                "marker": "ZBTB16",
                                "result": "(-)"
                            }
                        ],
                        "molecular": [],
                        "raw_text": "2022.03.28在全麻下行“瘤体减灭术+直肠乙状结肠部分切除术+阴道部分切除术+腹膜后病损切除术+复杂肠粘连松解术+左输尿管支架置管术+膀胱修补术。（部分直乙结肠+左侧腹膜后肿瘤+部分阴道）肠壁全层见高级别腺癌，结合T2022-04771首先考虑为透明细胞癌，正在加做免疫组化进一步明确。肿块大小约7*4*2.5cm。双侧切缘阴性，肠周淋巴结（4/15）见癌转移，伴癌结节1枚。（膀胱后壁肿瘤）纤维脂肪组织，局灶纤维组织增生、含铁血黄素沉积、泡沫样组织反应，未见癌累及。补充诊断1：【补充报告】（部分直乙结肠+左侧腹膜后肿瘤+部分阴道）可符合卵巢透明细胞癌累及。免疫组化（HI22-06789）瘤细胞：MLH1(ES05)（+），MSH6（+），MSH2（+），PMS2（+），ER（部分+），PR（少弱+），P53（+/-），WT1（-），Ki-67（60%+），HNF1B（+），NapsinA（灶+），P16（+），PAX8（+），SALL4（-），ZBTB16（-）",
                        "uncertainty_or_missing": [
                            "Molecular/genetic testing not reported",
                            "Definitive origin laterality not specified"
                        ]
                    }
                ]
            },
            "NUC_MED": {
                "studies": []
            },
            "LAB_TRENDS": {
                "labs": [
                    {
                        "analyte": "CA125",
                        "unit": "U/ml",
                        "reference_range": "Unknown",
                        "latest": {
                            "date": "2022-12-29",
                            "value": "933.00",
                            "flag": "↑"
                        },
                        "history": [
                            {
                                "date": "Unknown",
                                "value": "45.7",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-08-15",
                                "value": "14.90",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-10-12",
                                "value": "89.60",
                                "flag": "↑"
                            },
                            {
                                "date": "2022-11-17",
                                "value": "403",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-12-29",
                                "value": "933.00",
                                "flag": "↑"
                            }
                        ]
                    },
                    {
                        "analyte": "CA19-9",
                        "unit": "U/ml",
                        "reference_range": "Unknown",
                        "latest": {
                            "date": "2022-12-29",
                            "value": "229.00",
                            "flag": "↑"
                        },
                        "history": [
                            {
                                "date": "Unknown",
                                "value": "161",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-08-15",
                                "value": "7.16",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-10-12",
                                "value": "77.20",
                                "flag": "↑"
                            },
                            {
                                "date": "2022-12-29",
                                "value": "229.00",
                                "flag": "↑"
                            }
                        ]
                    },
                    {
                        "analyte": "HE4",
                        "unit": "pmol/L",
                        "reference_range": "Unknown",
                        "latest": {
                            "date": "2022-12-29",
                            "value": "111.00",
                            "flag": "↑"
                        },
                        "history": [
                            {
                                "date": "Unknown",
                                "value": "562",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-08-15",
                                "value": "87.90",
                                "flag": "↑"
                            },
                            {
                                "date": "2022-10-12",
                                "value": "59.70",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-12-29",
                                "value": "111.00",
                                "flag": "↑"
                            }
                        ]
                    },
                    {
                        "analyte": "AFP",
                        "unit": "ng/ml",
                        "reference_range": "Unknown",
                        "latest": {
                            "date": "2022-10-12",
                            "value": "<0.91",
                            "flag": "Unknown"
                        },
                        "history": [
                            {
                                "date": "2022-10-12",
                                "value": "<0.91",
                                "flag": "Unknown"
                            }
                        ]
                    },
                    {
                        "analyte": "Hb",
                        "unit": "g/L",
                        "reference_range": "Unknown",
                        "latest": {
                            "date": "2022-11-30",
                            "value": "94",
                            "flag": "Unknown"
                        },
                        "history": [
                            {
                                "date": "2022-11-10",
                                "value": "97",
                                "flag": "Unknown"
                            },
                            {
                                "date": "2022-11-30",
                                "value": "94",
                                "flag": "Unknown"
                            }
                        ]
                    }
                ],
                "milestones": [
                    {
                        "date": "2022-03-28",
                        "type": "Surgery",
                        "description": "Primary debulking surgery"
                    },
                    {
                        "date": "2022-08-17",
                        "type": "ChemoEnd",
                        "description": "Completed 6 cycles of 白紫+卡铂"
                    },
                    {
                        "date": "2022-10-12",
                        "type": "Relapse",
                        "description": "Biochemical relapse with rising CA125"
                    }
                ]
            }
        },
        "response": "Final Assessment:\nPlatinum‑resistant recurrent ovarian clear cell carcinoma with multifocal progression and severe anemia; current visit must focus on stabilization, goals of care, and deferring new oncologic interventions until status clarified.\n\nCore Treatment Strategy:\n- Immediately assess ECOG, detailed symptoms, and explicit goals/preferences during this visit before any new cancer therapy decisions.  \n- Urgently work up and correct severe anemia with full CBC/indices, iron studies, CMP, and coagulation profile [@20230103|2023-01-03].  \n- Defer new CT/MR/PET‑CT and extended biomarkers (MSI, PD‑L1, TMB, HER2) unless clearly management‑changing [@guideline:nccn_ovariancancer_v3_2025__v00000000|14].  \n- After stabilization, revisit with patient whether to pursue non‑platinum palliative systemic therapy versus best supportive care alone in this relapse setting [@guideline:nccn_ovariancancer_v3_2025__v00000000|15].  \n\nChange Triggers:\n- If anemia corrected and ECOG ≤2 with patient desiring active treatment, shift toward selecting a non‑platinum palliative systemic regimen.  \n- If ECOG poor, symptoms high, or patient prefers comfort‑focused care, pivot fully to best supportive and hospice‑oriented management.",
        "gold_plan": "可考虑参加临床试验（13916855649/15056967974）或换方案化疗。\n-检验科申请：血常规新(五分类)　肝功能(全套)　肾功能(不含血糖)检查地点：徐汇院区：东安路270号1号楼3楼检验科 。检验科申请：血常规新(五分类)　CA125(肿瘤抗原CA125)　HE4（卵巢癌）　CA15-3(肿瘤抗原CA15-3)检查地点：徐汇院区：东安路270号1号楼3楼检验科 。本科处置：静脉输液×7次　一次性使用精密过滤输液器带针W×7副　动静脉置管护理×7天　BD10ml预充式导管冲洗器×14个西药及中成药方：[甲]氯化钠注射液(百特)　0.9%*250ml×7袋/静滴　1袋/qd　d1-7[乙10%]蔗糖铁注射液(维乐福)　100mg*5ml*5支/盒×21支/静滴　3支/qd　d1-7[甲]氯化钠针(百特塑袋)　100ml*0.9%×7袋/静滴　1袋/qd　d1-7。本科处置：静脉输液×7次　一次性使用精密过滤输液器带针W×7副　动静脉置管护理×7天　BD10ml预充式导管冲洗器×14个西药及中成药方：※[乙0%]人促红素注射液(益比奥)　10000IU×3支/皮下　1支/qod　d1,3,5。本科处置：肌肉注射×3次",
        "question_raw": "卵巢恶性肿瘤：卵巢癌复发：术前CA125 45.7 CA199 161 HE4 562022.03.28在全麻下行“瘤体减灭术+直肠乙状结肠部分切除术+阴道部分切除术+腹膜后病损切除术+复杂肠粘连松解术+左输尿管支架置管术+膀胱修补术。（部分直乙结肠+左侧腹膜后肿瘤+部分阴道）肠壁全层见高级别腺癌，结合T2022-04771首先考虑为透明细胞癌，正在加做免疫组化进一步明确。肿块大小约7*4*2.5cm。双侧切缘阴性，肠周淋巴结（4/15）见癌转移，伴癌结节1枚。（膀胱后壁肿瘤）纤维脂肪组织，局灶纤维组织增生、含铁血黄素沉积、泡沫样组织反应，未见癌累及。补充诊断1：【补充报告】（部分直乙结肠+左侧腹膜后肿瘤+部分阴道）可符合卵巢透明细胞癌累及。免疫组化（HI22-06789）瘤细胞：MLH1(ES05)（+），MSH6（+），MSH2（+），PMS2（+），ER（部分+），PR（少弱+），P53（+/-），WT1（-），Ki-67（60%+），HNF1B（+），NapsinA（灶+），P16（+），PAX8（+），SALL4（-），ZBTB16（-）术后白紫+卡铂化疗6程，末次：2022.8.172022.08.15：CA19-9:7.16U/ml,CA125:14.90U/ml,CA15-3:30.30U/ml↑,CEA:1.92ng/ml,HE4:87.90pmol/L↑,ROMA:23.55%(绝经前)↑,ROMA.:18.89%(绝经后)MR（2022.07.17）：2022.08.15：CA19-9:7.16U/ml,CA125:14.90U/ml,CA15-3:30.30U/ml↑,CEA:1.92ng/ml,HE4:87.90pmol/L↑,ROMA:23.55%(绝经前)↑,ROMA.:18.89%(绝经后)肿瘤标志物（2022.10.12）：CA19-9:77.20U/ml↑,CA125:89.60U/ml↑,AFP:<0.91ng/ml,CEA:1.31ng/ml,HE4:59.70pmol/L,ROMA:12.07%(绝经前)↑,ROMA.:36.67%(绝经后)↑。CT（2022.10.25）：肝内多发结节，部分较前新见，转移可能，请结合MR检查。另见肝囊肿同前。MR（2022.10.24）：盆腔术后，骶前占位，考虑复发伴相邻骶骨受累可能。盆腔系膜多发强化小结节，转移可能。2022.11.10外院血常规：白细胞 2.36，红细胞 3.56，血红蛋白 97，血小板 153外院生化：ALP　105，NA 136，PAB 1242022.11.30外院血常规：白细胞 3.46，红细胞 3.48，血红蛋白 94，血小板 1342022.11.17外院肿瘤指标：CA125　403，Ca153　63.8，Ca199 96.8，Ca724 695肿瘤标志物（2022.12.29）：CA19-9:229.00U/ml↑,CA125:933.00U/ml↑,CA15-3:86.00U/ml↑,CEA:1.49ng/ml,NSE:9.06ng/ml,HE4:111.00pmol/L↑,ROMA:41.02%(绝经前)↑,ROMA.:85.98%(绝经后)↑。MR（2022.12.30）：盆腔术后，骶前占位范围较前增大、较前强化不均，考虑复发伴相邻腹膜、骶骨受累可能，请结合临床。右侧髂骨新见强化结节，转移可能。盆腔系膜多发强化小结节同前相仿，转移可能。直肠局部肠壁增厚伴强化。CT（2022.12.30）：肝内多发转移结节，较前增多，部分较前增大。另见肝囊肿同前。脾脏片状影，脾脏梗塞？随访。咨询报告",
        "Time": "2023-01-03 08:53:29.260000",
        "meta_info": "340123197709263626"
    }
]